Patients With Recurrent And Or Metastatic Solid Cancer clinical trials

Explore recruiting patients with recurrent and or metastatic solid cancer clinical trials.

Recruiting patients with recurrent and or metastatic solid cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Recurrent And Or Metastatic Solid Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CLEVER PEPTIDE : Open-label, non-controlled, multicenter, dose escalation, first-in-human clinical trial to evaluate the safety, pharmacokinetics and preliminary antitumor activity of intravenous PEP-010, administered as single agent and in combination with paclitaxel or with gemcitabine in patients with recurrent and/or metastatic solid cancer

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Patients With Recurrent And Or Metastatic Solid Cancer trials by city

Patients With Recurrent And Or Metastatic Solid Cancer in Toronto Patients With Recurrent And Or Metastatic Solid Cancer in Vancouver Patients With Recurrent And Or Metastatic Solid Cancer in Montreal Patients With Recurrent And Or Metastatic Solid Cancer in Calgary Patients With Recurrent And Or Metastatic Solid Cancer in Edmonton Patients With Recurrent And Or Metastatic Solid Cancer in Ottawa Patients With Recurrent And Or Metastatic Solid Cancer in Winnipeg Patients With Recurrent And Or Metastatic Solid Cancer in Quebec City Patients With Recurrent And Or Metastatic Solid Cancer in Hamilton Patients With Recurrent And Or Metastatic Solid Cancer in Kitchener Patients With Recurrent And Or Metastatic Solid Cancer in London Patients With Recurrent And Or Metastatic Solid Cancer in Halifax Patients With Recurrent And Or Metastatic Solid Cancer in New York Patients With Recurrent And Or Metastatic Solid Cancer in Los Angeles Patients With Recurrent And Or Metastatic Solid Cancer in Chicago Patients With Recurrent And Or Metastatic Solid Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease